c

e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors

20th September 2019 by Louise Hudman

e-learning | Ertugliflozin in type 2 diabetes and the other SGLT-2 inhibitors

This is a new guideline from NICE giving advice on ertugliflozin, published in April 2019. I am also doing a quick reminder about the other SGLT-2 inhibitors.

What is ertugliflozin?

It is another sodium-glucose co-transporter 2 (SGLT-2) inhibitor, like canagliflozin, dapagliflozin and empagliflozin.

It is thought to be as effective as the other SGLT-2 inhibitors, but it is cheaper.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

Related content

"I have tried a few different platforms but nothing compares to the comfort and practicality of LocumDeck. The NASGP support team is absolutely wonderful and they walked me through the initial set-up. Once the set-up is complete, the booking process is so easy and literally happens with the click of a button. I also love the paperless pension form submissions through LocumDeck and it takes me no more than two minutes each month to send all the necessary pension forms to PCSE. I have already recommended LocumDeck to all my colleagues and it is a must-have for anyone thinking about entering the GP locum world. I wish every practice in the country would sign up."

Dr Priya Arunachalam, GP, Southampton

See the full list of features within our NASGP membership plans

Membership